SEC Form 4 · accession 0001213900-19-000445
NEXEON MEDSYSTEMS INC · NXNN
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owners
William Rosellini
Officer — CHIEF EXECUTIVE OFFICER · Director · 10% Owner
Rosellini Scientific Holdings, LLC
10% Owner
Period of report
Jan 8, 2019
Accepted (ET)
Jan 9, 2019 · 2:15 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001416172
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1 | Jan 8, 2019 | G | 26,500 | — | D | 644,527 | I | Held by Rosellini Scientific Holdings, LLC |
| Common StockF1 | Jan 8, 2019 | G | 19,000 | — | D | 625,527 | I | Held by Rosellini Scientific Holdings, LLC |
| Common StockF1 | Jan 8, 2019 | G | 35,000 | — | D | 590,527 | I | Held by Rosellini Scientific Holdings, LLC |
| Common StockF1 | Jan 8, 2019 | G | 402,785 | — | D | 187,742 | I | Held by Rosellini Scientific Holdings, LLC |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1On January 8, 2019, Rosellini Scientific Holdings, LLC respectively gifted 26,500 shares of common stock of the Issuer to Elizabeth Rosellini, 19,000 shares to Michael Rosellini, 35,000 shares to Rosellini Family Irrevocable Trust UA Dated 09/24/2018, and 402,785 shares to Rosellini Family Irrv Tr 2.